Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Text Resource
|
Composition of patients undergoing pulmonary surgery before and after pandemic of COVID-19Research Square (Preprints), 20232023. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.21203/rs.3.rs-3196604/v1Digital Resources/Online E-Resources |
|
2 |
Material Type: Text Resource
|
I am a critical care nurseCritical care nurse, 2013, Vol.33 (2), p.92-80 [Peer Reviewed Journal]ISSN: 0279-5442 ;EISSN: 1940-8250 ;DOI: 10.4037/ccn2013795 ;PMID: 23547133Full text available |
|
3 |
Material Type: Text Resource
|
Characterization of Respiration-Induced Motion in Prone Versus Supine Patient Positioning for Thoracic Radiation Therapy2020 The Authors. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Digital Resources/Online E-Resources |
|
4 |
Material Type: Text Resource
|
Drowsiness detection by thoracic effort signal analysis in real driving environmentsinfo:eu-repo/semantics/openAccess ;ISBN: 9781424441228 ;ISBN: 1424441226Digital Resources/Online E-Resources |
|
5 |
Material Type: Text Resource
|
Pautes per a l'harmonització del tractament farmacoterapèutic del càncer de pulmó no microcític metastàticAttribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccessDigital Resources/Online E-Resources |
|
6 |
Material Type: Text Resource
|
Durvalumab per al tractament del càncer de pulmó no microcític estadi III irresecableAttribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccessDigital Resources/Online E-Resources |
|
7 |
Material Type: Text Resource
|
Alectinib, ceritinib, crizotinib i brigatinib per al tractament del càncer de pulmó no microcític localment avançat o metastàsic, posiyiu per la cinasa del limfoma anaplàstic (ALK)Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccessDigital Resources/Online E-Resources |
|
8 |
Material Type: Text Resource
|
Tractament i supervivència dels pacients amb neoplàsia del pulmó: anys 2014-2016 (14/2018)Atribución-NoComercial-SinDerivadas 3.0 España http://creativecommons.org/licenses/by-nc-nd/3.0/es/ info:eu-repo/semantics/openAccessDigital Resources/Online E-Resources |
|
9 |
Material Type: Text Resource
|
Osimertinib: indicació avaluada; tractament de pacients adults amb càncer de pulmó no microcític avançat o metastàsic amb mutació EGFR T790M positivaAttribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccessDigital Resources/Online E-Resources |
|
10 |
Material Type: Text Resource
|
On the modelling of cell and lipoprotein transport in the thoracic aortaDigital Resources/Online E-Resources |
|
11 |
Material Type: Text Resource
|
Blood rheology modeling effects in aortic flow simulationsDigital Resources/Online E-Resources |
|
12 |
Material Type: Text Resource
|
Atezolizumab: tractament del càncer de pulmó no microcític localment avançat o metastàtic en adults prèviament tractats amb quimioteràpiaAttribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccessDigital Resources/Online E-Resources |
|
13 |
Material Type: Text Resource
|
Ordenació i configuració del model organitzatiu dels serveis de cirurgia cardíaca (08/2014)Atribución-NoComercial-SinDerivadas 3.0 España http://creativecommons.org/licenses/by-nc-nd/3.0/es/ info:eu-repo/semantics/openAccessDigital Resources/Online E-Resources |